Identification of HIV-1protease cleavage site in human C1-inhibitor

被引:7
作者
Gerencer, M
Burek, V
机构
[1] Univ Zagreb, Univ Hosp, Dept Cellular Immunol, Tissue Typing Ctr, HR-10002 Zagreb, Croatia
[2] Univ Zagreb, Univ Hosp Infect Dis Dr Fran Mihaljevic, Dept Clin Immunol, HR-10002 Zagreb, Croatia
关键词
HIV-1; protease; limited proteolysis; complement proteins; protease cleavage site; pathogenesis;
D O I
10.1016/j.virusres.2004.04.010
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have investigated the ability of HIV-1 protease to cleave human complement proteins of the classical complement pathway: C1q, C2 and C4 as well as the regulatory protein, C1-inhibitor. Purified complement proteins were incubated with recombinant HIV-1 protease in vitro and analyzed by SDS-PAGE and immunoblotting assay. The only cleavage site was found in N-terminal region of C1-inhibitor, and it was located between residues Leu-32 and Phe-33 as determined by amino acid sequence analysis of the 85 kDa proteolyfic fragment after 12 Edman degradation cycles. The HIV-1 protease cleavage sites were not found in C1q, C2 and C4 protein. HIV-1 protease-susceptible site in N-terminal region of C1-inhibitor is very close to the cleavage sites of some other proteases that are able to induce N-terminal proteolysis of the protein. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 29 条
[1]  
A BEHRING GMBH, 2001, Patent No. 6242239
[2]   The Protein Information Resource (PIR) [J].
Barker, WC ;
Garavelli, JS ;
Huang, HZ ;
McGarvey, PB ;
Orcutt, BC ;
Srinivasarao, GY ;
Xiao, CL ;
Yeh, LSL ;
Ledley, RS ;
Janda, JF ;
Pfeiffer, F ;
Mewes, HW ;
Tsugita, A ;
Wu, C .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :41-44
[3]   PURIFICATION AND CHARACTERIZATION OF THE RNASE H DOMAIN OF HIV-1 REVERSE-TRANSCRIPTASE EXPRESSED IN RECOMBINANT ESCHERICHIA-COLI [J].
BECERRA, SP ;
CLORE, GM ;
GRONENBORN, AM ;
KARLSTROM, AR ;
STAHL, SJ ;
WILSON, SH ;
WINGFIELD, PT .
FEBS LETTERS, 1990, 270 (1-2) :76-80
[4]   Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development [J].
Beck, ZQ ;
Hervio, L ;
Dawson, PE ;
Elder, JH ;
Madison, EL .
VIROLOGY, 2000, 274 (02) :391-401
[5]   ANTIBODY-RESPONSE TO HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 PROTEASE ACCORDING TO RISK GROUP AND DISEASE STAGE [J].
BOUCHER, CAB ;
DEJAGER, MH ;
DEBOUCK, C ;
EPSTEIN, LG ;
DEWOLF, F ;
WOLFS, TFW ;
GOUDSMIT, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (07) :1577-1581
[6]  
Chou KC, 1996, PROTEINS, V24, P51, DOI 10.1002/(SICI)1097-0134(199601)24:1&lt
[7]  
51::AID-PROT4&gt
[8]  
3.0.CO
[9]  
2-R
[10]   Hepatitis C virus NS3 serine protease interacts with the serpin Cl inhibitor [J].
Drouet, C ;
Bouillet, L ;
Csopaki, F ;
Colomb, MG .
FEBS LETTERS, 1999, 458 (03) :415-418